1. Home
  2. TIL vs ARAY Comparison

TIL vs ARAY Comparison

Compare TIL & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$11.32

Market Cap

177.1M

Sector

Health Care

ML Signal

HOLD

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$1.08

Market Cap

170.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIL
ARAY
Founded
2018
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.1M
170.1M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
TIL
ARAY
Price
$11.32
$1.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$100.67
$4.50
AVG Volume (30 Days)
73.2K
1.2M
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$450,902,000.00
Revenue This Year
N/A
$3.82
Revenue Next Year
N/A
$4.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.51
52 Week Low
$10.70
$0.91
52 Week High
$42.79
$2.95

Technical Indicators

Market Signals
Indicator
TIL
ARAY
Relative Strength Index (RSI) 38.95 45.46
Support Level $10.76 $0.95
Resistance Level $11.51 $1.06
Average True Range (ATR) 0.88 0.07
MACD 0.15 0.02
Stochastic Oscillator 24.64 80.99

Price Performance

Historical Comparison
TIL
ARAY

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Share on Social Networks: